Follow the people · Insider
Arjun Agarwal
Arjun Agarwal files insider transactions with the SEC as a senior vice president, finance of Oruka Therapeutics (ORKA). We hold 7 disclosed purchases and sales filed since 24 January 2025, 5 of them in the last 90 days.
- Files forORKA
- Disclosed buys and sells7 in all, 5 in the last 90 days
- Last disclosure14 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 22 January 2025 — 13 August 2026Senior Vice President, Finance · Oruka Therapeutics (ORKA)42 Form 4 lines · source: SEC Form 4
Everything they disclosed
42 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 8,542 shares of Oruka TherapeuticsSEC Form 414 August 2026Common Stock · traded 13 August 2026 · filed 14 August 2026
- exercised options over 1,458 shares of Oruka TherapeuticsSEC Form 414 August 2026Common Stock · traded 13 August 2026 · filed 14 August 2026
- ▼ sold on the open market 2,100 shares of Oruka TherapeuticsSEC Form 414 August 2026Common Stock · traded 13 August 2026 · filed 14 August 2026
- ▼ sold on the open market 2,132 shares of Oruka TherapeuticsSEC Form 414 August 2026Common Stock · traded 13 August 2026 · filed 14 August 2026
- ▼ sold on the open market 1,268 shares of Oruka TherapeuticsSEC Form 414 August 2026Common Stock · traded 13 August 2026 · filed 14 August 2026
- ▼ sold on the open market 2,142 shares of Oruka TherapeuticsSEC Form 414 August 2026Common Stock · traded 13 August 2026 · filed 14 August 2026
- ▼ sold on the open market 2,358 shares of Oruka TherapeuticsSEC Form 414 August 2026Common Stock · traded 13 August 2026 · filed 14 August 2026
- exercised options over 8,542 shares of Oruka Therapeutics (a derivative holding)SEC Form 414 August 2026Employee Stock Option (right to buy) · traded 13 August 2026 · filed 14 August 2026
- exercised options over 1,458 shares of Oruka Therapeutics (a derivative holding)SEC Form 414 August 2026Employee Stock Option (right to buy) · traded 13 August 2026 · filed 14 August 2026
- exercised options over 8,541 shares of Oruka TherapeuticsSEC Form 413 July 2026Common Stock · traded 13 July 2026 · filed 13 July 2026
- exercised options over 1,458 shares of Oruka TherapeuticsSEC Form 413 July 2026Common Stock · traded 13 July 2026 · filed 13 July 2026
- ▼ sold on the open market 300 shares of Oruka TherapeuticsSEC Form 413 July 2026Common Stock · traded 13 July 2026 · filed 13 July 2026
- ▼ sold on the open market 3,743 shares of Oruka TherapeuticsSEC Form 413 July 2026Common Stock · traded 13 July 2026 · filed 13 July 2026
- ▼ sold on the open market 5,656 shares of Oruka TherapeuticsSEC Form 413 July 2026Common Stock · traded 13 July 2026 · filed 13 July 2026
- ▼ sold on the open market 300 shares of Oruka TherapeuticsSEC Form 413 July 2026Common Stock · traded 13 July 2026 · filed 13 July 2026
- exercised options over 8,541 shares of Oruka Therapeutics (a derivative holding)SEC Form 413 July 2026Employee Stock Option (right to buy) · traded 13 July 2026 · filed 13 July 2026
- exercised options over 1,458 shares of Oruka Therapeutics (a derivative holding)SEC Form 413 July 2026Employee Stock Option (right to buy) · traded 13 July 2026 · filed 13 July 2026
- ▼ sold on the open market 888 shares of Oruka TherapeuticsSEC Form 422 June 2026Common Stock · traded 22 June 2026 · filed 22 June 2026
- ▼ sold on the open market 699 shares of Oruka TherapeuticsSEC Form 422 June 2026Common Stock · traded 22 June 2026 · filed 22 June 2026
- exercised options over 8,000 shares of Oruka TherapeuticsSEC Form 415 June 2026Common Stock · traded 12 June 2026 · filed 15 June 2026
- exercised options over 1,459 shares of Oruka TherapeuticsSEC Form 415 June 2026Common Stock · traded 12 June 2026 · filed 15 June 2026
- ▼ sold on the open market 1,859 shares of Oruka TherapeuticsSEC Form 415 June 2026Common Stock · traded 12 June 2026 · filed 15 June 2026
- ▼ sold on the open market 4,340 shares of Oruka TherapeuticsSEC Form 415 June 2026Common Stock · traded 12 June 2026 · filed 15 June 2026
- ▼ sold on the open market 3,260 shares of Oruka TherapeuticsSEC Form 415 June 2026Common Stock · traded 12 June 2026 · filed 15 June 2026
- ▼ sold on the open market 395 shares of Oruka TherapeuticsSEC Form 415 June 2026Common Stock · traded 15 June 2026 · filed 15 June 2026
- exercised options over 8,000 shares of Oruka Therapeutics (a derivative holding)SEC Form 415 June 2026Employee Stock Option (right to buy) · traded 12 June 2026 · filed 15 June 2026
- exercised options over 1,459 shares of Oruka Therapeutics (a derivative holding)SEC Form 415 June 2026Employee Stock Option (right to buy) · traded 12 June 2026 · filed 15 June 2026
- exercised options over 2,000 shares of Oruka TherapeuticsSEC Form 418 May 2026Common Stock · traded 18 May 2026 · filed 18 May 2026
- exercised options over 5,833 shares of Oruka TherapeuticsSEC Form 418 May 2026Common Stock · traded 18 May 2026 · filed 18 May 2026
- ▼ sold on the open market 4,190 shares of Oruka TherapeuticsSEC Form 418 May 2026Common Stock · traded 18 May 2026 · filed 18 May 2026
- ▼ sold on the open market 4,600 shares of Oruka TherapeuticsSEC Form 418 May 2026Common Stock · traded 18 May 2026 · filed 18 May 2026
- ▼ sold on the open market 800 shares of Oruka TherapeuticsSEC Form 418 May 2026Common Stock · traded 18 May 2026 · filed 18 May 2026
- ▼ sold on the open market 700 shares of Oruka TherapeuticsSEC Form 418 May 2026Common Stock · traded 18 May 2026 · filed 18 May 2026
- exercised options over 2,000 shares of Oruka Therapeutics (a derivative holding)SEC Form 418 May 2026Employee Stock Option (right to buy) · traded 18 May 2026 · filed 18 May 2026
- exercised options over 5,833 shares of Oruka Therapeutics (a derivative holding)SEC Form 418 May 2026Employee Stock Option (right to buy) · traded 18 May 2026 · filed 18 May 2026
- ▼ sold on the open market 395 shares of Oruka TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 395 shares of Oruka TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- was granted 17,500 shares of Oruka TherapeuticsSEC Form 423 January 2026Common Stock · traded 23 January 2026 · filed 23 January 2026
- was granted 70,000 shares of Oruka Therapeutics (a derivative holding)SEC Form 423 January 2026Employee Stock Option (right to buy) · traded 23 January 2026 · filed 23 January 2026
- was granted 70,000 shares of Oruka Therapeutics (a derivative holding)SEC Form 423 January 2026Employee Stock Option (right to buy) · traded 23 January 2026 · filed 23 January 2026
- was granted 17,500 shares of Oruka TherapeuticsSEC Form 423 January 2026Common Stock · traded 23 January 2026 · filed 23 January 2026
- was granted 120,000 shares of Oruka Therapeutics (a derivative holding)SEC Form 424 January 2025Employee Stock Option (right to buy) · traded 22 January 2025 · filed 24 January 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.